Tuesday, November 26, 2024
Home Authors Posts by Editor / Curator

Editor / Curator

928 POSTS 0 COMMENTS
Internet Stock Review
Biotech News

And it’s Official. We Have Another Double. BioSig (BSGM) up 103%...

Editor / Curator -
Biotech News

Adding Brainstorm Therapeutics (BCLI) $4.59 to CoronaVirus Watchlist.

Editor / Curator -
Stem Cells

Heads Up! Big News on Stem Cells & Covid This Weekend.

Editor / Curator -
OMNIQ
Cybersecurity

First Zebra (ZBRA) Then Checkpoint (CHKP), OMNIQ (OQMS) Strengthens Product Line-Up.

Editor / Curator -
Satori Capital. Hapbee
Telehealth

Investment Manager With $1 Billion in Assets Under Management, Buys 300...

Editor / Curator -
Internet Stock Review
Bitcoin

And We Have Our First Bitcoin Double.

Editor / Curator -
Biotech News

Adding ENDRA Life Sciences (NDRA) $0.89 to Watch List.

Editor / Curator -
Biotech Stock Review
Biotech News

Video: Okay, You Tested Positive for Corona, Now What?

Editor / Curator -
Hepion Pharma HEPA
Biotech News

News, As Huge As It Gets, From Hepion Pharma (HEPA) $2.10.

Editor / Curator -
Hapbee, EMulate, HAPB
Telehealth

A Medical Technology That Has The Highest Potential Over Any ...

Editor / Curator -
1...535455...93Page 54 of 93

Latest article

Nine Page Summary Report on GeoVax (GOVX)

2024 Watch List Editor / Curator -
This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

2024 Watch List Editor / Curator -
Award of BARDA Project NextGen contract represents a significant milestone event; Total value...

Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.

All News Editor / Curator -
Can You Imagine Selling Solgenix at $2.00 yesterday. And to be honest, news wasn't all that big - such...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.